PED
PEDEVCO Corp.
PED lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
PED Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Unavailable | |
| Healthy |
PED's revenue and balance sheet are currently healthy, and its profitability is stable. There isn't enough data to rate its cash flow.
PED PE Valuation
PED has no meaningful PE right now: it lost money over the past year.
PED Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect PED's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
PED Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.98 | — |
| Q3 2026 | -$4.52 | -552% |
| Q2 2026 | -$3.82 | -339% |
| Q1 2026 | -$5.53 | -313% |
| Q4 2025 | -$2.25 | -180% |
| Q3 2025 | $1.00 | +150% |
| Q2 2025 | $1.60 | +$1.60 |
| Q1 2025 | $2.60 | +$2.80 |
| Q4 2024 | $2.80 | +$2.80 |
PED has swung to a loss: it lost $4.52 per share over the past year, after a profit the year before.
PED Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.5M | +411% |
| Q2 2026 | $46.1M | +561% |
| Q1 2026 | $40.2M | +360% |
| Q4 2025 | $14.2M | +34% |
| Q3 2025 | $7M | -23% |
| Q2 2025 | $7M | -41% |
| Q1 2025 | $8.7M | +7.6% |
| Q4 2024 | $10.6M | +57% |
PED's revenue has grown year over year for four quarters in a row: $36M last quarter, up 411% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | +37 points |
| Q2 2026 | 33% | +66 points |
| Q1 2026 | 17% | +15 points |
| Q4 2025 | -35% | -22 points |
| Q3 2025 | -12% | -43 points |
| Q2 2025 | -32% | -55 points |
| Q1 2025 | 1.7% | -5.9 points |
| Q4 2024 | -13% | +49 points |
PED's operating margin was 25% last quarter, up 37 points from the same quarter a year ago.
PED Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.6M | +29% |
| Q2 2026 | $15.3M | +$15.8M |
| Q1 2026 | $10.5M | +78% |
| Q3 2025 | $7.4M | -10% |
| Q2 2025 | -$420K | -109% |
| Q1 2025 | $5.9M | +$10.2M |
| Q4 2024 | $4.2M | -65% |
| Q3 2024 | $8.3M | +170% |
PED generated $43M in free cash flow over the past year, up 138% from the year before.
PED Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
PED's net debt is about 1.2 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
PED Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 58.2 | Neutral |
PED's weekly RSI is 48 (neutral) and its Stochastic is 58 (neutral).
PED PE vs Energy Sector
| Metric | PED | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
PED has no meaningful PE right now: it lost money over the past year.
PED Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.1 | 7.2% below |
| 20 week MA | $13.2 | 1% below |
| 50 week MA | $13.4 | 2.7% below |
| 100 week MA | $13.2 | 1.4% below |
| 200 week MA | $15.6 | 17% below |
PED is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
PED Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.8 | $24.4 | -32% |
| 2021 | $24.4 | $21.8 | -11% |
| 2022 | $21.8 | $23.2 | +6.4% |
| 2023 | $23.2 | $15.4 | -34% |
| 2024 | $15.4 | $14.9 | -3% |
| 2025 | $14.9 | $11.1 | -26% |
| 2026 YTD | $11.1 | $13.1 | +18% |
PED has finished three years in a row lower, and it's up 18% so far in 2026.